Allergic and pseudo-allergic reactions to vaccines;Les réactions allergiques et pseudo-allergiques aux vaccins

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 44, Issue 5, 2004, Pages 461-468

  Ponvert, C ^a   Scheinmann, P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Allergie vaccinale; IgE sp cifiques; IgG sp cifiques; Skin tests; Specific IgE; Specific IgG; Tests cutan s; Vaccine allergy

Indexed keywords

ANATOXIN; ANTIBIOTIC AGENT; ANTIGEN; BCG VACCINE; DEXTRAN; DIPHTHERIA VACCINE; GELATIN; HEPATITIS B VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEOMYCIN; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; PROPIOLACTONE; TETANUS TOXOID; VACCINE;

ABSCESS; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTHRALGIA; ARTHUS PHENOMENON; ASTHMA; DESENSITIZATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; ECZEMA; ERYTHEMA MULTIFORME; HUMAN; HYPERSENSITIVITY REACTION; INFLAMMATION; REVIEW; SERUM SICKNESS; SKIN NODULE; SKIN TEST; URTICARIA; VASCULITIS;

EID: 4444354800     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.allerg.2004.03.002     Document Type: Short Survey

References (111)

1. Cryz S.J. Bacterial vaccines. Cryz S.J. Immunotherapy and vaccines. 1991;13-75 VCH, Wenheim (Germany)
2. Drucker J. Vaccinations: bases immunologiques et microbiologiques, indications, contre-indications, accidents, efficacité Rev Prat. 41:1991;2001-2004
3. Bernstein D.I., Smith V.E., Schiff G.H., Rathfon H.M., Boscia J.A. Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and four to six years of age. Pediatr Infect Dis. 12:1993;131-135
4. Carey A.B., Meltzer E.O. Diagnosis and « desensitisation » in tetanus vaccine hypersensitivity. Ann Allergy. 69:1992;336-338
5. Jacobs R.L., Lowe R.S., Lanier B.Q. Adverse reactions to tetanus toxoid. J Am Med Assn. 247:1982;40-42
6. Long S.S., Deforest A., Smith D.G. Longitudinal study of adverse reactions following diphteria-tetanus-pertussis vaccine in infancy. Pediatrics. 85:1990;294-302
7. Mortimer E.A., Sorensen R.U. Urticaria following administration of diphteria-tetanus toxoid-pertussis vaccine. Pediatr Infect Dis J. 6:1987;876-877
8. André F. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine. 8:(S):1990;74-78
9. Caillard J.F., Bastard C., Czernichow P., Lemarchand C., Proust B., Prudent P. Effets secondaires de la vaccination contre l'hépatite A, virus B: étude sur 1047 sujets au CHRU de Rouen. LARC Med. 5:1985;129-132
10. Dienstag J.L., Werner B.G., Polk F., Snydman D.R., Craven D.E., Platt R., et al. Hepatitis B vaccine in health care personnel: safety, immunogenicity and indicators of efficacy. Ann Intern Med. 101:1984;34-40
11. McMahon B.J., Helminiak C., Wainwright R.B., Bulkow L., Trimble B.A., Wainwright K. Frequency of adverse reactions to hepatitis B vaccine in 43 618 persons. Am J Med. 91:1992;254-255
12. Szmuness W., Stevens C.E., Harley E.J., Zang E.A., Oleszko W.R., William D.C., et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N Engl J Med. 303:1980;833-841
13. Andrews R.M., Kempe A.E., Herceg A. Vaccinating children with a history of serious reactions after vaccination or of egg allergy. Med J Austr. 168:1998;491-494
14. Gold M., Goodwin H., Botham S., Burgess M., Nash M., Kempe A. Revaccination of 421 children with a past history of an adverse reaction in a special immunization service. Arch Dis Child. 83:2000;128-131
15. Kobayashi R.H. Vaccinations. Immunol Allergy Clin N Amer. 15:1995;553-566
16. Poley G.E., Slater J.E. Drug and vaccine allergy. Immunol Allergy Clin N Amer. 19:1999;409-422
17. Bakonde V.B., Ponvert C., Le Clainche L., Brunet D., Scheinmann P., Paupe J. Les réactions aux vaccins contre l'hépatite B chez l'enfant: résultats d'une étude de quatre cas. Rev Fr Allergol. 38:1998;315-318
18. Piletta P.A., Pasche-Koo F., Saurat J.H., Hauser C. Immediate local reaction to tetanus toxoid booster. Allergy. 52:1997;676-677
19. Ponvert C., Scheinmann P., Karila C., Bakonde V.B., Le Bourgeois M., de Blic J. L'allergie aux vaccins associés chez l'enfant: une étude de 30 cas fondée sur les tests cutanés à lecture immédiate, semi-retardée et retardée, sur les dosages des anticorps spécifiques et sur les injections de rappel. Rev Fr Allergol Immunol Clin. 41:2001;701-711
20. Skov P.S., Pelck I., Ebbesen F., Poulsen L.K. Hypersensitivity to the diphteria component in the Di-Te-Pol vaccine: a type I allergic reaction demonstrated by basophil histamine release. Pediatr Allergy Immunol. 8:1997;156-158
21. Aukrust L., Almeland T.L., Refsum D., Aas K. Severe hypersensitivity or intolerance reactions to measles vaccine in six children. Allergy. 35:1980;581
22. Baxter D.N. Measles immunization in children with a history of egg allergy. Vaccine. 14:1996;131-134
23. Beck S., Williams L.W., Shirrell M.A., Burks A.W. Egg hypersentitivity and measles-mumps-rubella vaccine administration. Pediatrics. 88:1991;913-917
24. Fasano M.B., Wood R.A., Cooke S.K., Sampson H.A. Egg hypersensitivity and adverse reactions to measles, mumps and rubella vaccine. J Pediatr. 120:1992;878-881
25. Herman J.J., Radin R., Schneiderman R., et al. Allergic reactions to measles (rubella) vaccine in patients hypersensitive to egg protein. J Pediatr. 102:1983;196-199
26. Vourga V., Tapratzi P., Panayatopoulou K. Measles-mumps-rubella vaccine (MMR) in egg-allergic children. Allergy. 52:1997;96
27. Inoue S., Sakaguchi M., Ogura H. IgE-mediated systemic reactions to gelatin included in vaccines. J Allergy Clin Immunol. 97:1996;364. (Abst. 726)
28. Kelso J.M., Jones R.T., Yunginger J.W. Anaphylaxis to measles, mumps and rubella vaccine mediated by IgE to gelatin. J Allergy Clin Immunol. 91:1993;867-872
29. Kumagai T., Yamanaka T., Wataya Y., Umetsu A., Kawamura N., Ikeda K., et al. Gelatin-specific humoral and cellular immune responses in children with immediate- and non immediate-type reactions to live measles, mumps, rubella and varicella vaccines. J Allergy Clin Immunol. 30:1997;1430-1435
30. Levy Y., Kornbroth B., Danon Y.L. Allergic reaction to measles-mumps-rubella (MMR) vaccine in a girl tolerant to egg protein. J Allergy Clin Immunol. 97:1996;239. (Abst. 227)
31. Sakaguchi M., Nakayama T., Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. J Allergy Clin Immunol. 98:1996;1058-1061
32. Sakaguchi M., Yoshida M., Kuroda W., Harayama O., Matsunaga Y., Inouye S. Systemic immediate-type reactions to gelatin included in Japanese Encephalitis vaccines. Vaccine. 15:1997;121-122
33. Singer S., Johnson C.E., Mohr R., Holowecky C. Urticaria following varicella vaccine associated with gelatin allergy. Vaccine. 17:1999;327-329
34. Sissman N.J. Allergic reactions to MMR vaccine. Pediatrics. 88:1992;168-169
35. Ponvert C., Ardelean-Jaby D., Colin-Gorski A.M., Soufflet B., Hamberger C., de Blic J., et al. Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination. Vaccine. 19:2001;4588-4591
36. Fauquert J.L., Tridon A., Labbé A., Perrier C. Réaction anaphylactoïde post-BCG: le rôle du dextran ? Rev Fr Allergol Immunol Clin. 41:2001;412-414
37. Ponnighaus J.M., Fine P.E.M., Moreno C. Hypersensitivity to dextran in BCG vaccine. Lancet. 337:1991;1039
38. Rudin C., Amacher A., Berglund A. Anaphylactoid reaction associated with BCG vaccination. Lancet. 337:1991;377
39. Rudin C., Günthard J., Halter C., Staehelin J., Berglund A. Anaphylactoid reaction to BCG vaccine containing high molecular weight dextran. Eur J Pediatr. 154:1995;941-942
40. Böhler-Sommereger K., Lindemayr H. Contact sensitivity to aluminium. Contact Derm. 15:1986;278-281
41. Cox N.H., Moss C., Forsyth A. Allergy to non-toxoid constituents of vaccines and implications for patch testing. Contact Derm. 18:1988;143-146
42. Cox N.H., Moss C., Forsyth A. Cutaneous reactions to aluminium in vaccines: an avoidable problem. Lancet. ii:1988;43
43. Fisher A.A. Reactions to aluminium and its salts. Cutis. 33:1984;154-159
44. Gall Y., Stalder J.F., Mousset F., Daculsi G. Mise en évidence de l'aluminium dans un nodule sous-cutané secondaire à une vaccination par le Tétracoq. Ann Dermatol Venereol. 116:1989;79
45. Guinnepain M.T. Eczéma après vaccination. Médecine Staff-Allergologie. 3:1992;10-11
46. Noel I., Galloway A., Ive F.A. Hypersensitivity to thiomersal in hepatitis B vaccine. Lancet. 338:1991;705
47. Rietschel R.L., Adams R.M. Reactions to thimerosal in hepatitis B vaccine. Contact Derm. 8:1990;161-164
48. Ring J. Exacerbation of eczema to formalin-containing hepatitis B vaccine in formaldehyde-allergic patient. Lancet. ii:1986;522-523
49. Church J.A., Richard W. Recurrent abcess formation following DTP immunizations: association with hypersensitivity to tetanus toxoid. Pediatrics. 75:1985;899-900
50. Sakaguchi M., Miyazawa H., Inouye S. Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines. Ann Allergy Asthma Immunol. 84:2000;341-344
51. Sakaguchi M., Miyazawa H., Inouye S. Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese Encephalitis vaccines. Allergy. 56:2001;536-539
52. Taniguchi K., Fujisawa T., Ihara T., Kamiya H. Gelatin-induced T-cell activation in children with non anaphylactic-type reactions to vaccines containing gelatin. J Allergy Clin Immunol. 102:1998;1028-1032
53. Facktor M.A., Bernstein R.A., Fireman P. Hypersensitivity to tetanus toxoid. J Allergy Clin Immunol. 52:1973;1-12
54. Scheifele D.W., Meekison W., Grace M., Barreto L., Carter A.O., Mitchell L., et al. Adverse reactions to the preschool (fifth) dose of adsorbed diphtteria-pertussis-tetanus vaccine in Canadian children. Can Med Assn J. 145:1991;641-647
55. Rennels M.B., Deloria M.A., Pichichero M.E., Losonsky G.A., Englund J.A., Meade B.D., et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphteria vaccines. Pediatrics. 105:2000;e12 (6 p)
56. Rennels M.R., Deloria M.A., Pichichero M.E., Englund J.A., Anderson E.L., Steinhoff M.C., et al. Lack of consistent relationship between quantity of aluminium in diphteria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine. 20:2002;544-547
57. Yamamoto A., Nagata N., Ochiai M., Kataoka M., Okada K., et al. Enhanced sensitisation of mice with diphteria-tetanus-acellular pertussis vaccine to local swelling reaction to the booster immunization. Vaccine. 20:2002;3088-3094
58. Delafuente J.C., Eisenberg J.D., Hoelzer D.R., Slavin R.G. Tetanus toxoid as an antigen for delayed cutaneous hypersensitivity. J Am Med Assn. 249:1983;3209-3211
59. Johnson C., Walls R.S., Ruwoldt A. Delayed hypersensitivity to tetanus toxoid in man: in vivo and in vitro studies. Pathology. 15:1983;369-372
60. Fairschter R.D., Thornton D.B., Gottschalk H.R., Slater L.M., Galant S.P. In Vivo and in vitro cell-mediated immunity to tetanus toxoid in adults. J Allergy Clin Immunol. 66:1980;452-457
61. Dittmann S. Immunobiological preparations. 12th ed Dukes M.N.G. Meyler Side Effects of Drugs. 1992;820 ESBV, London (England)
62. Nichol K.L., Mac Donald R., Hauge M. Side effects associated with pneumococcal vaccination. Am J Infect Control. 25:1997;223-228
63. SAMA-SA Pulmonol Soc Working Group. Adult pneumococcal vaccination guideline. S Afr Med J. 89:1999;1222-1230
64. Osawa J., Kitamura K., Ikezawa Z., Nakajima H. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity. Contact Derm. 24:1991;178-182
65. Tosti A., Vicenzi C., Peluso A.M. Accidental diagnosis of aluminium sensitivity with Fynn chambers. Contact Derm. 8:1982;343
66. Veien N.K., Hattel T., Justesen O., Nøcholm A. Aluminium allergy. Contact Derm. 15:1986;295-297
67. Aberer W. Vaccination despite thimerosal sensitivity. Contact Derm. 24:1991;6-10
68. Hansson G., Möller H. Cutaneous reactions to merthiolate and their relationship to vaccination with tetanus toxoid. Acta Allergol. 26:1971;150-156
69. Bordet A.L., Michenet P., Cohen C., Arbion F., Ekindi N., Bonneau C., et al. Granulome post-vaccinal lié à l'hydroxyde d'aluminium. Ann Pathol. 21:2001;149-152
70. Castelain P.Y., Castelain M., Vervloet D., Garbe L., Mallet B. Sensitisation to aluminum by aluminium-precipitated dust and pollen extracts. Contact Derm. 19:1988;58-60
71. Nagore E., Martinez-Escribano J.A., Tata A., Sabater V., Vilata J.J. Subcutaneous nodules following treatments with aluminium-containing allergen extracts. Eur J Dermatol. 11:2001;138-140
72. Slater D.N., Underwood J.C.E., Durrant T.E., Gray T., Hopper I.P. Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis. Brit J Dermatol. 107:1982;103-108
73. Pineau A., Durand C., Guillard O., Stalder J.F. Role of aluminium in skin reactions after diphteria-tetanus-poliomyelitis vaccination: an experimental study in rabbits. Toxicology. 73:1992;117-125
74. Brindle M.J., Twyman D.G. Allergic reactions to tetanus toxoid. Brit Med J. 1:1962;1116-1117
75. Lewis K., Jordan S.C., Cherry J.D., Sakai R.S. Petechiae and urticaria after DTP vaccination: detection of circulating immune complexes containing vaccine-specific antigens. J Pediatr. 109:1986;1009-1012
76. Dannemann A., Van Ree R., Kulig M., Bergmann R.L., Bauer P., Forster J., et al. Specific IgE and IgG4 immune responses to tetanus and diphteria toxoid in atopic and non atopic children during the first two years of life. Int Arch Allergy Immunol. 111:1996;262-267
77. Aalberse R.C., Van Ree R., Dannemann A., Wahn U. IgE antibodies to tetanus toxoid in relation to atopy. Int Arch Allergy Immunol. 107:1995;169-171
78. Nagel J., Svec D., Waters T., Fireman P. IgE synthesis in man. I-Development of specific IgE antibodies after immunization with Tetanus-Diphteria (Td) toxoids. J Immunol. 118:1977;334-340
79. Fabry H. Formaldehyde sensitivity: two interesting cases. Contact Derm News Lett. 3:1968;51
80. Cody C.L., Baraff L.J., Cherry J.D. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 68:1981;650-660
81. Pollock T.M., Morris J. A 7-year survey of disorders attributed to vaccination in North West Thames region. Lancet. i:1983;753-757
82. Smith R.E., Wolnitsky C. Allergic reactions to tetanus, diphteria, influenza and poliomyelitis immunization. Ann Allergy. 20:1962;809-813
83. Leung A.K.C. Anaphylaxis to DPT vaccine. J Royal Soc Med. 78:1985;175
84. Ovens H. Anaphylaxis due to vaccination in the office. Can Med Assn J. 134:1986;369-370
85. Zaloga G.P., Chernow R. Life-threatening anaphylactic reactions to tetanus toxoid. Ann Allergy. 49:1982;106-107
86. Deloria M.A., Blackwelder W.C., Decker M.D., Englund J.A., Steinhoff M.C., Pichichero M.E., et al. Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations. Pediatrics. 96:(S):1995;592-594
87. Ajjan N. Les vaccinations chez l'enfant. II-Vaccinations et pathologie. Rev Pediatr. 3:1990;105-106
88. Decker M.D., Edwards K.M., Steinhoff M.C., Rennels M.B., Pichichero M.E., Englund J.A., et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics. 96:(S):1995;557-566
89. Edelman K., Malmström K., He Q., Savolainen J., Terho E.O., Mertsola J. Local production and IgE antibodies to pertussis toxin after acellular diphteria-tetanus-pertussis immunization. Eur J Pediatr. 158:1999;989-994
90. Hedenskog S., Björksten B., Blennow M., Granström G., Grandström M. Immunoglobulin E response to pertussis toxin in whooping cough and after immunisation with a whole-cell and an acellular pertussis vaccine. Int Arch Allergy Appl Immunol. 89:1989;156-161
91. Nilsson L., Grüber C., Granström M., Bjorksten B., Kjellman N.I. Pertussis IgE and atopic disease. Allergy. 53:1998;1195-1201
92. Kosecka U., Berin M.C., Perdue M.H. Pertussis adjuvant prolongs intestinal hypersensitivity. Int Arch Allergy Immunol. 119:1999;205-211
93. Ishizaka K. Cellular events in the IgE antibody response. Adv Immunol. 23:1976;1-75
94. Aalberse R.C., Dannemann A., Van Ree R., Wahn U. The human IgE response to diphteria/tetanus in vivo is suppressed rather than enhanced by covaccination with B. pertussis. J Allergy Clin Immunol. 94:1995;361. (Abst. 881)
95. Brightman C.A., Scadding G.K., Dumbreck L.A., Latchman Y., Brostoff J. Yeast-derived hepatitis B vaccine and yeast hypersensitivity. Lancet. 22:1989;903
96. Correia O., Nunes J.P., Vaz-da-Silva M.J., Pires S., Brandao F., Mesquita-Guimaraes J. Acute exanthematous pustular dermatitis after pneumococcal vaccine. Dermatology. 196:1993;215-216
97. Lavi S., et al. Administration of measles, mumps and rubella virus vaccine (live) to egg-allergic children. J Am Med Assn. 263:1990;269-271
98. Khakoo G.A., Lack G. Guidelines for measles vaccination in egg-allergic children. Clin Exp Allergy. 30:2000;288-293
99. Lakshman R., Finn A. MMR vaccine and allergy. Arch Dis Child. 82:1999;93-97
100. Patja A., Makinen-Kiljunen S., Davidkin I., Paunio M., Peltola H. Allergic reactions to measles-mumps-rubella vaccination. Pediatrics. 107:2001;e27 (7 p)
101. Ohsaki M., Tsutsumi H., Kumagai T., Yamanaka T., Wataya Y., Furukawa H., et al. The relevance of Th1 and Th2 cells in immediate and non-immediate reactions to gelatin-containing vaccines. J Allergy Clin Immunol. 103:1999;276-281
102. Kumagai T., Ozaki T., Kamada M., Igarashi C., Yuri K., Furukawa H., et al. Gelatin-containing diphteria-tetanus-pertussis (DTP) vaccine causes sensitisation to gelatin in the recipients. Vaccine. 18:2000;1555-1561
103. Cheson B. BCG therapy and urticaria. Ann Intern Med. 82:1975;738
104. Dextran-induced anaphylactoid reactions in man. Role of dextran-reactive antibodies. Int Arch Allergy Appl Immunol. 52:1976;145-159
105. Kwittken P., Rosen S., Sweinberg S. MMR vaccine and neomycin allergy. Am J Dis Child. 147:1993;128
106. Rietschel R.L., Bernier R. Neomycin sensitivity in the MMR vaccine. J Am Med Assn. 13:1981;245
107. Bellanti J.A., Fishman H.J., Wientzen R.L. Adverse reactions to vaccines. Immunol Allergy Clin N Amer. 7:1987;423-445
108. Swanson F.C., Rosanoff E., Gurwith M., Deitch M., Schnurrenberger P., Reed C.E. IgE and IgG antibodies to beta-propionolactone and human serumalbumin associated with urticarial reactions to rabies vaccine. J Infect Dis. 155:1987;909-913
109. Kumagai T., Nakayama T., Kamada M., Igarashi C., Yuri K., Furukawa H., et al. The lymphoproliferative response to enzymatically digested gelatin in subjects with gelatin hypersensitivity. Clin Exp Allergy. 30:2000;1430-1435
110. Nakayama T., Aizawa C. Change in gelatin content of vaccines associated with reduction in reports of allergic reactions. J Allergy Clin Immunol. 106:2000;591-592
111. André F., Cavagna S., André C. Gelatin prepared from tuna skin: a risk factor for fish allergy or sensitization? Int Arch Allergy Immunol. 130:2003;17-24